[TEVA] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -116.68%
YoY- 97.05%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 4,295,000 4,559,000 4,529,000 4,701,000 5,065,000 5,459,000 5,610,000 -16.32%
PBT -84,000 -3,387,000 -213,000 -250,000 1,254,000 -13,208,000 119,000 -
Tax 9,000 -139,000 -26,000 -76,000 46,000 -1,471,000 -494,000 -
NP -105,000 -2,886,000 -208,000 -176,000 1,055,000 -11,535,000 530,000 -
Tax Rate - - - - -3.67% - 415.13% -
Total Cost 4,400,000 7,445,000 4,737,000 4,877,000 4,010,000 16,994,000 5,080,000 -9.14%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -2.44 -63.30 -4.59 -3.74 20.83 -211.30 9.45 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.10 -2.80 -0.21 -0.18 1.04 -11.34 0.52 -
EPS Diluted -0.10 -2.80 -0.20 -0.17 1.03 -11.34 0.52 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.